Xingxing L. Diao
State Key Laboratory Of Drug Research
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications
Understanding the ocular accumulation of mefuparib and its N-dealkylation metabolite: Pharmacokinetics, melanin affinity, and cellular disposition.
Journal: Experimental eye research
Published: April 29, 2026
Mechanistic study on the species differences in metabolism and excretion pathways of ivarmacitinib between humans and rats.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: April 23, 2026
Pharmacokinetics, Mass Balance, and Metabolism of [14C]TPN729, a Selective and Potent Phosphodiesterase Type 5 Inhibitor in Humans.
Journal: Biomedical chromatography : BMC
Published: March 04, 2026
Benchmarking In Silico Metabolite Prediction Tools against Human Radiolabeled ADME Data for Small-Molecule Drugs.
Journal: Journal of chemical information and modeling
Published: February 12, 2026
Metabolite Profiling and Identification of Semaglutide in Liver S9 Across Species and Rat Plasma.
Journal: Biomedical chromatography : BMC
Published: December 29, 2025
Development and Validation of a Rapid LC-MS/MS Method for the Quantification of Contezolid in Human Plasma and Liver, and Its Application to a Pharmacokinetic Study in Liver Transplant Patients.
Journal: Biomedical chromatography : BMC
Published: October 27, 2025
A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases.
Journal: Nature
Published: July 20, 2025
A case of pulmonary nodules and cysts associated with hypereosinophilia
Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: June 10, 2025
Metabolism of the Total Flavonoid Extract of Lithocarpus litseifolius (Hance) Chun in Rats.
Journal: Biomedical chromatography : BMC
Published: June 04, 2025
Pharmacokinetics, mass balance, and metabolism of [14C]SAF-189s, a potent anaplastic lymphoma kinase/c-ROS proto-oncogene 1 inhibitor in humans: Metabolism potentially affected by interaction of cytochrome P450 enzymes and intestinal microbiota.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: May 01, 2025
Impact of NPAS2 on mPFC dopamine synthesis and nap behavior.
Journal: Nature communications
Published: April 24, 2025
Last Updated: 09/26/2026